Form 4: Nephros Inc. Director Oliver J. Spandow Reports Changes in Beneficial Ownership
SEC Form 4
Director Oliver J. Spandow reports acquisition and disposal of Nephros Inc. common stock and grants of stock options.
Summary
- On January 1, 2025, Oliver J. Spandow, a director of Nephros Inc., reported changes in beneficial ownership of the company's securities.
- Spandow acquired 33,241 shares of common stock at $0 and disposed of an unspecified amount, resulting in a total of 114,845 shares beneficially owned following the transaction.
- Spandow was also granted options to purchase 7,050 shares of common stock at an exercise price of $1.47, vesting in three annual installments starting January 1, 2025, and expiring on January 1, 2035.
- The report also details Spandow's existing holdings of stock options with various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, with neutral sentiment. The stock disposal could be a minor concern, but the option grant is a positive.
Positives
- The granting of stock options to a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.
Negatives
- The disposal of an unspecified amount of common stock by the director could be interpreted negatively by some investors.
Risks
- The report does not provide specific reasons for the stock disposal, which could create uncertainty among investors.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The reported transactions may influence investor sentiment regarding Nephros Inc.
Key Dates
| Date | Description |
|---|---|
| 01/05/2023 | Date on which 2,360 shares of one stock option vested. |
| 01/05/2024 | Date on which 2,360 shares of one stock option vested. |
| 05/14/2024 | Date on which 2,441 shares of one stock option vested. |
| 01/01/2025 | Date of the reported transactions: acquisition and disposal of common stock, and grant of stock options; Date on which 2,360 shares of one stock option vested; Date on which 2,350 shares of a new stock option vests. |
| 01/03/2025 | Date of signature for the report. |
| 01/05/2025 | Date on which 2,360 shares of one stock option vested. |
| 05/14/2025 | Date on which 2,441 shares of one stock option vested. |
| 01/01/2026 | Date on which 2,350 shares of a new stock option vests. |
| 05/14/2026 | Date on which 2,441 shares of one stock option vested. |
| 01/01/2027 | Date on which 2,350 shares of a new stock option vests. |
| 08/10/2028 | Expiration date of one stock option. |
| 12/19/2028 | Expiration date of one stock option. |
| 12/16/2029 | Expiration date of one stock option. |
| 01/06/2031 | Expiration date of one stock option. |
| 12/14/2031 | Expiration date of one stock option. |
| 01/05/2033 | Expiration date of one stock option. |
| 05/14/2034 | Expiration date of one stock option. |
| 01/01/2035 | Expiration date of one stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.